CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-01 | Tessari Eben CHIEF OPERATING OFFICER | Shares withheld for taxes | −521 | $19.70 | $10K | 124,099 |
| 2024-04-01 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Restricted Share Unit | −1,773 | 5,318 | ||
| 2024-04-01 | Patel Sanj K CHAIRMAN & CEO | Option exercise | +6,482 | 58,998 | ||
| 2024-04-01 | Patel Sanj K CHAIRMAN & CEO | Shares withheld for taxes | −1,903 | $19.70 | $37K | 57,095 |
| 2024-04-01 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Restricted Share Unit | −6,482 | 19,443 | ||
| 2024-04-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise | +2,558 | 20,146 | ||
| 2024-04-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −1,084 | $19.70 | $21K | 19,062 |
| 2024-04-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Unit | −2,558 | 7,672 | ||
| 2024-04-01 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise | +1,612 | 16,032 | ||
| 2024-04-01 | Moat Ross CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −880 | $19.70 | $17K | 15,152 |
| 2024-04-01 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Share Unit | −1,612 | 4,833 | ||
| 2024-04-01 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise | +1,624 | 46,516 | ||
| 2024-04-01 | Paolini John F. CHIEF MEDICAL OFFICER | Shares withheld for taxes | −477 | $19.70 | $9K | 46,039 |
| 2024-04-01 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Restricted Share Unit | −1,624 | 4,872 | ||
| 2024-03-07 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −65,012 | $21.02 | $1.4M | 0 |
| 2024-03-06 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −5,582 | $21.00 | $117K | 65,012 |
| 2024-03-04 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −9,406 | $21.31 | $200K | 73,930 |
| 2024-03-04 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −3,336 | $22.00 | $73K | 70,594 |
| 2024-03-01 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +656 | $1.59 | $1K | 124,036 |
| 2024-03-01 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −1,189 | $22.03 | $26K | 122,847 |
Page 54 of 74 · 1,467 trades